Mankind Pharma Ltd
BSE: 543904
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 2.6K-1.9% | 2.6K+0.9% | 2.6K+2.7% | 2.5K+19.5% | 2.1K-11.3% | 2.4K-5.3% | 2.5K |
| Other Income | 126.70+124.2% | 56.52-27.2% | 77.67+20.9% | 64.22-70.7% | 219.32+214.1% | 69.82-34.0% | 105.76 |
| Total Income | 2.7K+0.7% | 2.7K+0.1% | 2.7K+3.1% | 2.6K+11.1% | 2.3K-4.9% | 2.5K-6.4% | 2.6K |
| EXPENSES | |||||||
| Expenditure | 1.9K-9.7% | 2.1K-2.8% | 2.2K+2.4% | 2.1K+10.2% | 1.9K-1.3% | 1.9K+4.1% | 1.9K |
| Tax | 74.40+33.3% | 55.82-15.1% | 65.73-18.8% | 80.90+74.8% | 46.29-57.1% | 107.87-35.8% | 168.01 |
| PROFIT | |||||||
| PBT | 788.01+56.0% | 505.29-3.7% | 524.63+6.3% | 493.66+15.1% | 428.75-18.2% | 524.25-32.0% | 770.45 |
| Net Profit | 713.61+58.8% | 449.47-2.1% | 458.90+11.2% | 412.76+7.9% | 382.46-8.1% | 416.38-34.4% | 634.43 |
| KEY METRICS | |||||||
| OPM % | 34.70%+8.31pp | 26.39%-0.18pp | 26.57%+0.09pp | 26.48%+4.05pp | 22.43%+15.42pp | 7.01%-15.81pp | 22.82% |
| NPM % | 26.35%+9.64pp | 16.71%-0.37pp | 17.08%+1.24pp | 15.84%-0.46pp | 16.30%-0.58pp | 16.88%-5.98pp | 22.86% |
| EPS | 17.29+58.8% | 10.89-2.1% | 11.12+11.2% | 10.00+7.9% | 9.27-10.4% | 10.35-31.2% | 15.04 |
Corporate Events
Board MeetingMANKIND
20264Aug
Board Meeting
The 35th Annual General Meeting ("AGM") of the Members of Ma…
BSE Filing ↗ Board MeetingMANKIND
202514Apr
Board Meeting
Constitution of a ‘Structural Integration Committee’, Incorp…
BSE Filing ↗ Board MeetingMANKIND
20245Nov
Board Meeting
consider and approve the unaudited standalone and consolidat…
BSE Filing ↗